Acetamoren – (950841-87-9)

Acetamoren is a next-generation synthetic ghrelin receptor agonist engineered as a superior analog of Ibutamoren (MK-677). With enhanced receptor selectivity, improved pharmacokinetics, and a fluorinated thioether backbone for metabolic stability, Acetamoren delivers potent, tissue-selective anabolic effects without the drawbacks of earlier compounds. It boasts a half-life of 8–10 hours and sustains IGF-1 elevation for up to 22 hours post-administration.

Designed for advanced research applications, Acetamoren demonstrates:

• 92% higher GHS-R1a receptor binding (Ki = 0.8 nM)

• Dual action as a somatostatin receptor modulator (SSTR2/5)

• Reduced hunger stimulation (68% less than MK-677)

• No effect on cortisol or glucose metabolism

Ideal for studies on sarcopenia, CNS recovery, growth plate regeneration, and spaceflight-induced muscle atrophy, Acetamoren supports increased muscle mass, nitrogen retention, and skin elasticity. 

Key Features:

• Optimized for muscle-selective IGF-1 activation

• Moisture-stable and longer-lasting than MK-677

• Does not interact with androgen receptors or disrupt endocrine balance

Acetamoren is a cutting-edge tool for researchers exploring regenerative therapies and advanced anabolic mechanisms.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.